Guillain-Barré syndrome
What public evidence exists on this topic, and what kind of evidence each piece is. Each section is a different kind of evidence from a different system; the numbers are never added together.
VAERS reports Adverse-event report (unverified)
- 1,151 COVID-19 vaccine reports listing guillain-barre syndrome rows
- guillain-barre syndrome
VAERS reports are unverified, have no denominator, and do not show that a vaccine caused anything. One report can list several terms, so terms overlap.
V-safe structured check-ins Self-reported health event
V-safe's check-the-box questions recorded general categories (symptoms, missed work, medical care, hospitalization), not specific conditions, so they hold no guillain-barré syndrome-specific counts. See Safety Data for the category counts.
V-safe narratives Self-reported health event
The narrative index is not available yet.
FDA and CDC findings and actions Regulatory signal / recognized adverse reaction
- Recognized adverse reaction Guillain-Barré syndrome warning added for the Janssen vaccine; ACIP reaffirms its use Superseded
FDA revised the Janssen fact sheets to note an observed increased risk of Guillain-Barré syndrome in the 42 days after vaccination; ACIP reviewed the data and concluded benefits outweighed risks.
Compensation (CICP) Compensation claim / claim compensated
- 387 CICP COVID-19 vaccine claims whose alleged injury text mentions this topic (as of Jul 1, 2026) rows
- 2 compensated COVID-19 vaccine claims for this covered injury, $10,537 paid (as of Mar 1, 2026) rows
Claims are allegations; a payment is a program determination under CICP rules, not a scientific finding. COVID-19 vaccines are not covered by the VICP.
Litigation Lawsuit allegation
No tracked case is tagged with this topic.
Studies and public records Epidemiologic association / public record
No study or public record on this topic has been added yet.